| 000 | 01850 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516061829.0 | ||
| 264 | 0 | _c20120710 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a1439-3646 | ||
| 024 | 7 |
_a10.1055/s-0031-1291248 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDieckmann, A | |
| 245 | 0 | 0 |
_aTreatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation. _h[electronic resource] |
| 260 |
_bExperimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association _cMar 2012 |
||
| 300 |
_a132-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCentral Nervous System Stimulants _xpharmacology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xchemically induced |
| 650 | 0 | 4 |
_aDiabetic Neuropathies _xpathology |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHeme _xanalogs & derivatives |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPoly Adenosine Diphosphate Ribose _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPoly(ADP-ribose) Polymerase Inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSensory Receptor Cells _xdrug effects |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aStreptozocin |
| 700 | 1 | _aKriebel, M | |
| 700 | 1 | _aAndriambeloson, E | |
| 700 | 1 | _aZiegler, D | |
| 700 | 1 | _aElmlinger, M | |
| 773 | 0 |
_tExperimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association _gvol. 120 _gno. 3 _gp. 132-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0031-1291248 _zAvailable from publisher's website |
| 999 |
_c21252294 _d21252294 |
||